Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure

Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler

Source: Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
Journal Issue: March
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006



Correction of endothelial dysfunction in patients with pulmonary diseases
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008


Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012

Cytokines status, endothelial function in patients with pulmonary diseases
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Systemic inflammation and endothelial dysfunction in patient with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 143s
Year: 2007

Iloprost protects against lung endothelial barrier dysfunction and vascular leak via Rap1
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009



PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009


Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 706s
Year: 2005

Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019


Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008



Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury
Source: Eur Respir J 2013; 41: 165-176
Year: 2013



Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007

Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

CXCL5-dependent neutrophil recruitment harms lung barrier function in acute lung injury
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018

Endothelial barrier function during lung injury
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008



Vascular dysfunction and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


Impaired lung function is associated with systemic inflammation and macrophage activation
Source: Eur Respir J 2015; 45: 557-559
Year: 2015


Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002

Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001